CBIO Competitors & Alternatives
Compare Crescent Biopharma, Inc. with similar stocks in the same industry
Biotechnology
CBIO
Main Stock$14.37
Tradestie Score
51
Market Cap
$199.71M
Analyst Upside
+119.2%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SVRA
Savara Inc.
|
$4.72
|
$611.84M | - | 57 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 49 | Compare |
|
VSTM
Verastem, Inc.
|
$8.44
|
$541.60M | - | 54 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$10.62
|
$540.97M | - | 40 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$11.16
|
$529.35M | 9.7 | 43 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$1.82
|
$512.39M | - | 38 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$45.69
|
$505.12M | 2.7 | 59 | Compare |
|
RGNX
REGENXBIO Inc.
|
$8.03
|
$493.52M | - | 32 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$87.75
|
$492.21M | - | 39 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 46 | Compare |
More CBIO Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry